Yüklüyor......
Reports of Lactic Acidosis Attributed to Metformin, 2015–2018
OBJECTIVE: In 2016, the U.S. Food and Drug Administration (FDA) revised metformin’s label to permit use in patients with mild-moderate chronic kidney disease. We sought to determine whether this change was associated with increased reports of metformin-associated lactic acidosis (MALA) to the FDA’s...
Kaydedildi:
| Yayımlandı: | Diabetes Care |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Diabetes Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011199/ https://ncbi.nlm.nih.gov/pubmed/31597667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0923 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|